Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Common Equity (2016 - 2025)

Historic Common Equity for Kewaunee Scientific (KEQU) over the last 15 years, with Q4 2025 value amounting to $71.7 million.

  • Kewaunee Scientific's Common Equity rose 2088.22% to $71.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $71.7 million, marking a year-over-year increase of 2088.22%. This contributed to the annual value of $66.2 million for FY2025, which is 1785.48% up from last year.
  • Latest data reveals that Kewaunee Scientific reported Common Equity of $71.7 million as of Q4 2025, which was up 2088.22% from $68.9 million recorded in Q3 2025.
  • In the past 5 years, Kewaunee Scientific's Common Equity ranged from a high of $71.7 million in Q4 2025 and a low of $35.0 million during Q4 2022
  • For the 5-year period, Kewaunee Scientific's Common Equity averaged around $47.2 million, with its median value being $41.0 million (2021).
  • In the last 5 years, Kewaunee Scientific's Common Equity crashed by 1279.2% in 2022 and then skyrocketed by 4605.43% in 2024.
  • Quarter analysis of 5 years shows Kewaunee Scientific's Common Equity stood at $37.3 million in 2021, then dropped by 6.15% to $35.0 million in 2022, then grew by 24.01% to $43.4 million in 2023, then surged by 36.66% to $59.3 million in 2024, then increased by 20.88% to $71.7 million in 2025.
  • Its Common Equity stands at $71.7 million for Q4 2025, versus $68.9 million for Q3 2025 and $66.2 million for Q2 2025.